Clinical Trial Update: CROSSOVER STUDY OF ON-DEMAND PREP FORMULATIONS COMPARING RECTAL AND ORAL TENOFOVIR [Phase 2]

View source ↗

Summary

Phase 2 crossover trial evaluating on-demand rectal versus oral Tenofovir for HIV pre-exposure prophylaxis; study is currently active but not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Drugs mentioned

• Tenofovir (Tenofovir)

Snippet

Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) | Conditions: Tenofovir | Phase 2 | Status: ACTIVE_NOT_RECRUITING